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INTRODUCTION

The purposes of this paper are to present a brief
summary of the history of Brucellosis, with short d1s
cu$s1ons of its epidemiology, and bacteriology.

The

diagnosis of Brucellosis will be taken up in some de
tail, as will the �ymp�omatology and the physical signs.
The chief purpose of this paper is to present a review
of the literature on the treatment of Brucellosis. This
review, for the most pa.rt ts confined to those articles

wb1ch are written in the English

language, and which

are ava1iable 1n tris library.
My interest in tbis topic was stimulated one day
while making a ca11 in oonnectlon with the outeall ser
vice of the dispensary.

Purely by accident I stopped at

a wrong address in the South Omaha housing projec_t.

A

middle�aged man of color opened the door and asked me in,
saying that be had some questions which he would like to
ask me.

He stated that, about one year before, while

working in a meat,;.p�ok1ng plant he had become 111 and w·as
told that he had undulant fever.

He had been under treat

.ment since that time, and had not been able to go back
to his former job.

He also stated tbat a blood test had

been ta�en recently, the results of which indicated that

he had

eyphtft,ts.

'He mted to- know 1-f ther_e was- a

�£ltf�\:b111t_y f,bat the :uooulan_t fever had cau§� h1m t.G-
acqu1re a pos1:��fve blood 'test tor -syphB.J;JJ.

-�" re-

t'l:t�ing- home I :1.--ooked up the subjeet .._ ana be�- unable -to find the answer t-o tnat spec1f1e quest.in� -de
cided to look further.

In sea.rcehing tor this.:- informs.-

t).on rrry interest. 1n the question o-r Brucellos-1s and its

treatment was aroused.
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HISTORICAL
Alth-Ough brucellosis has been recogn1 7 ed as a
definite disease for only a comparatively short time,
1t is really an ancient disease.

Among the diseases

described by the early Greek physician, Hippocrates,
was a protraeted fever, which was characterized by
rel�pees or remissions.

In some ways th1s disease

was thought to resemble tuberculosus, but it did not
have the fatal termination of tuberculosus.
disease was probably bruoellos1s.

Th�e

Marston, in 1863,

reported a disease which he called "Mediterranean

rem1tt.ent fever", and gave a description of it.
fever was

This

endemic 1n the whole mediterranean area. (1)

In 1887 Bruce published a report of 91 cases or
"Mediterranean rem1tt.ent fever".

These cases had an

average stay in the hosp1 tal of 85_.5 days, and were
characterized by a high fever.

The fever was seen in

three different types, continued, remittent, or intermit
tent.

An

unaulatory curve was' seen frequently.

'l'bere

would be p'er1ods of pyrexia, s-eparted by periods of
apyrexia.

The

initial period of pyrex1a was usually the

longest, (20 to 30 days).

This was fo11-owed by a period

of apyrex1a, usually of 10 or 15 days; then another
period of fever, lasting about 15 days, before the next
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remission.

In th1s series of cases he notlced tbat the

sple€n was often enlarged.

Post-mortem examination of

a fatal case revealed a g reatly enla_pged spleen.

Ex

amination -0f the spieen, microseopi-0ally, showed the
presence of many m1c-roeocci..
was cultured.
cultures.

The next day the spleen

After 168 hours, growth was noted in the

Examination of these colonies- sh-owed them to

be a-mail m1erooocc1.

Similar results were obtained in

three additional cases.

Bruce theref-ore concluded ,_ th�t

these m1crococc1 were the causative agent of bruoe11os1s,
or-Malta fever, as it was c�lled at that time.. (2)

In

1888 Brµoe reported the results of further 1nvesttgat1on

of this m1cr.oooccua.

He reported that he had t aken cul

tures from fatal cases of Malta fever and ino<iulated
them into healthy monkeys.

The monkeys developed a dis

ease similar to Malta fever in man.

Autopsy on these

monkefs revealed the same orga�1sms 1n their spleens as
had been recovered from the spleens of human cases at
auto-psy. (3) Bruce named this. organtsm t-he Microoocous
Mel 1 t:ens 1s.
In 1897, B$ng, a Danish veterin�rian, r�covered a
bacillus from the exudate present 1n tbe uteri of cows
that had aborted.

He re:over-ed thts same baelllus from

the fetal membr anes �nd from the fetus itself.

He showed

that the injection of this bacillus into the va-gina of a
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healtby, pregn�n�-cow would cause the cow to abort, and
he

again recovered the same organism from the fe�us

and the fetal membranes.

This experiment was also tri'ed

1n pregnant ewes and in a pregnant mare.

These animals

aborted, and the organ1sms were. again recovered.

He

found that the patho1ogy was an inflammation of the uter
ine mucosa, a placent1t1s, and edema of the fetal mem
branes.

The organi�ms were seen in two different forms,

a coccus and a short�p1ump bacillus, the latter being
seen most often in cultures, and the former in the patho
logical ma�erial. (4)

This organ1sm was given the name

Bacillus abort.us.
The investigations by Bruee and Bang were not eon
neo�ed and were

wholely independent.

It was not until

Alice Evans, in 1916, showed tha� these organisms were
very closely related.

She reported that the causattv:e

agent of Malta fever was re.ally a rod form, and sug
ges:ted that 1t be called Bact. melitens1s.

She also re

ported that the Bact. melitensts and the Bact. abortus
were so closely related that the only way 1n which they
could be d1st1ngu1shed was by the use of agglutination
tests.

Bact. melitensis suspensions were a gglutinated

in higher dilutions of melitens1s serum than would ag
glutinate suspensions of Bact. abort us. (5)

Tbis was

-eonf1rmed by Meyer and Shaw, in 1920, who also sug-
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geeted that �he organisms be given the generic name
Bruoella. (6)

This work was probably the result of a

report '.by Bassett-Smith in 1914, in which he rep:>rted
that he had found that unh�ated cow's milk ·would agglutinate Bact. melitensis.

He also .. found that boU�-

1ng -the cow's milk would prevent the reaction. (7)
The first cases of brucellosis which were re
ported in th� United states were those reported by
Bogert in 1896.

These cases were all tn sa1lo-�s who

had returned from European stations.
showed weakness and malaise.

These cases all

They all had an erevation

or· temperat�re of from 100° to 105° .

The fever was of

the most varied types, continuous, intermittent. or re
mi tterit.

·There were frequent relapses which were

usually not as severe as the orf_g1rial at.tao ks.

Some of

the patient·s had rheumatic pains of the joints and limbs,
attended in some cases by inflammation of the affeoted

0parts.

In no case were there any symptoms pointing to

an ent-er1c 1nf'ect1.t
<: n. (8)

The next cases reported 1n

the United States were reported by Musser and Sa1-ler,
1n 1899.

Their case had just returned from Puerto ·Rico.

He bad noticed malaise and a headache, and a :finer which
was hi,_sher 1n the eventng than in t:t;l.e mornt_ng..

W1dal

tests were negative, as were examinations for the
malarial organisms.

It was found tnat he had a positive
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agglutination reaetio-n wtth B!'ucella _me).1.tensis. (9)
Another oase was reported by Cox ·1n 1899.

This ease was

that of a eoldter who had J::u-st returned t-o. the country.
He had bad chills, fever, a.norex1.a, insomnia, diarrhea,
and then -0onstipat10-n.

daily remiss tons.

His �perature c-ur-v-e showed

At'ter h_a.ving. had .fever of three

mon�rs, there was a remission of seven to eight days,
after whieh he had fever agaln.

In this ease also, Widal

te-c:S ts were ne_gat1ve, and no malarial org_anlsms were
found 1n the bl..ood.

The �ggluttnation reaction with

Brucella melitensi:a was found to be oos1t1ve. (10) In
1906 Cratg reported the case of an Army nurse who had
never been out of �he country.

·tnere �ere no cases of

brucellosis 1n the hospital at the time she became ill
She eomplaln-ed of bead.Ache, pain in the regton of the
spleen, and muscular pain, espe-c-1.;1.lly marked near the
Joints.

Agglutination rea.:q_tlons with "9rucell.a

melltenats were str,ngly positive. (11)

This was tbe.

first• proved case o( brucellosis 1n tbe Ufilted States
that had not been outside the continental l1m1te of tb.e
country, and so far as ~wa-s kn.�·wn, had no.t.. been 1n contact
w1 th anyone with the disease.
The d1seovery of tLe: manner in wh1¢h bruo�llos1s
ls

spread

W111

be

re�rted

1n

the

s�ction

on

Epidem1ol.ogy, and the discovery of the agglutination
reaction
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w:11.l be reported in the sectton o� Dlagnos1B of
Bru.cellosis.
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For a.Tmost_ 20 year.e aft.er t'.}J� d.1seovery or -th�
causative

!18--e:nt ..of

nrue---e-1.losf·s, the manne-r- 1n which

the d-tseaee -was sp�-e:�a-a was not known.

-rt was the

op 1n1orr or- B-ruo e · ]:.bat t.lre disease was S:P��fatt · by_ the
faulty- sewage J!_Js-p�s-al; tn tne--towns o!�the Mediterr

anean.

tag.1ous.

He did not� belie:v� that b-r-ucell.-0-eis was· con-
He was also ot the opinion th�t 1� con-

ferre� a lasting immunity. (12)

Th¢ �heory that

brucellosis was spread ?Y sewage po1.lution .of ground

and harbors was sh ared w 1th Brue e
also by Climo. (i4)

b-y Hugh-es, (1_3) and

0

The discovery of th� actual man-

ner of spread of th� disease was made -by Zammi t in 1905.

He found that the or�;;-an:1.sms were present in thtr milk or
goats on the ial.and of Malta.
te have a �sttt1s.

These goats were found

There was foupd_ to be a high in

cidence o-f abortion among t-he 1nt-ectea go.ate, and goats

that had aborted were found 'fio_ have the o_rgan1sms. 1n

their milk. {15} 'In 1912, Eyre show�d that there was a

direct relationship betwe�n the numb�r__of infected 60�ts
and the' island of ·-Malta and the ine-1dence of bruoe'rl-bsl:&.

especially in the native population. {16)

A £urvey by

Ste_w.ens, in i922, showed that the substitution o� eva
porated milk for goats milk bad resulted in a sharp fall
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in the incidence of brucellosis among the m11itary and
naval populations o-f Malta.

There had not been a cor

responding fall 1n the incidence 1n the civilian popul
t1on. (17) an epidemic of bruceiiosia occurred 1n Phoenix,
Arizona, in 1922.

Thia epidemic was traced to the sale

of infected goat's milk. (19)

A fatal case of brucel

losis in a Utah g-oat•herder 1s reported by Tyndale_ and
V1ko� 1n 1923.

In This case all laboratory examinations

had been negative, but culture of the spleen at postmortem examination was positive for Brucella melltensis.
(20)
One of the first real attempts to link brucel
los1s caused by Brucella abortus and brucellosis caused
by Brucella melitensis was made by Bevan in 1921.

He

again called attention to the close morphological and
biological resemblance of the tw-0 organisms.

He also

called attention to the close r-ela tionshlp serologically..

The chief symptom of the disease in cattle and in goats
ls abortion.
Rhodesia.

He tells of cases occurring in Southeran

These cases were seen 1n persons, who, as far

as was known; had no.t been rn contact with infected
goats and bad not used milk fro� goats.

These persons

had lived and .worked on farms however, where the cattle
were i_nfected with infecti:ous abortion. (21)

The first
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proved case of bruce-llos1s due t o Brucel la abortua
in the United States_, was reported by Keefer, in 1924;
In this case the organism was isolated and was identi
fied as Brue.el la abortue. (22}

The tenet that undulant fever could be caused by

Brucella abortus was not held by all.
made the following statement:

0

In ·1926, smith

statements based on re

cent comparative studies of B-. abortus and B. melit�n
s1s have bee-n made to the efr-ee.t that these t"'A'o orgArusms
are 1dent1oal and that a clinical complex similar

to

Malta or Undulant fever may be p.rQduced in man by B.
abortus.

On the other hand, the well defined geo

graphical limitations of M�lta -fever and its relatiQn to
goat's milk, the high degree of infectiousness of B.
melt te-ns1s towards labora-�0,rt work-era handling this or

ganism, and the wide dif-fueion of it'lt'ectious_ abortion in

cattle througbqut Western Europe and the United &tat.es,
a1.l militate against this 1dentif1cat1on." (23)

There were -others who acce-pt.ed. this belief and pre-sented more cas.es to help substantiate it.

Two of these

cases were presented by Merriam and Ca�penter.

The or�

ganisms isolated in these eases were round to be 1nd1e
tfnguishable from Brucella a.bortus and were snown to be
different rrom Bruoella mel1tens1s.

Injection of some

of the culture int,:ravenously into pregnant heif-ers cau�ed

10

them to �bort
.

Both patient s- were ;eno1n1 t.0-- -�

qonsume�s of raw milk :ai•ic r'or- milk �uct.s.
cas� the-m1;ut_�waa- found to be- n�_avtly
Brucella abortus.
farm

duri�

�eavy:

In one

90-�a��

wlt�

The otlie:r pat1en� had _warted on a dairy

-tfi:e -summer.

e:t;-n�r-farm had h� swine- for

t��e "��-rs-" and no -$.bortion had been not1c� in tlle swine
when th�y had b.e'� kt?pt.

Neti,h-ar ,of the pa;ttents had drunk

g.oa"t;'s milk or eaten goat i s m1lk produets. {24}

HuJ1 and

Blaek �ported fo-tir oatres of' brucellosis thought to be due

to Brucella abor�us�- but agg_l_utin1n absotp!,1o-n testa, whl-eh

_are necesa:ary to.- make the d1fl'erent1at1on between" the
abo_rtua and
mel1 ten-s-±s -groups, were not, done.

-Tb�t coneli.lded that -the

probable source or lnfect1nn 1Jl these cases wa� infected
cattle. (5)
tiQn.

Smith was Jater -willing to modffy bis posi

In expltl�t1-on ,-of the •�re_ or less sudden sporadic

�I,!e.'�ra�e or- undulant or Mal.t-a -:re-v�r �t.; a distance from its
�up¢�ed center around the -MedLterranean* 1� be advan<:_ed t.he
t:heory that the organism had re� 1atively recently on th!.e
c-ontinent developed_ a pathogenic 1 ty for- man, :alth�� to
bls knowle-4-g� 1 t_ had been present 1n cattle since 1893-,
apparently w1 thout causing any 1nf?ctJ.on 1n huma-n beings,
and is due to the infection of swine from cattle.

In thts

passage the virulence -Of t.be organ_1sm 1-� greatly ex�lted and

then

- 11 -

re-infection of cattle occurs with this more virulent
strain, resulting in the appearance of the disease in
man. ( 26)
The firet careful study of the �pidemiology of
brucellosis in the United States was made by Hardy of
the Iowa State Dep�rtment of Health.

In summarizing

his preliminary report he makes the following statement: . "It seems from the evidence that the infection
in only some of the cases is transmitted through the
medium of milk, This.but serves to emphasize the fact
that this disease cannot be· controlled entirely
through pasteurization of milk, though undoubtedly
such a procedure would aid in control.

The prevent.ion

of undulant fever occurring largely on the farms, in
small towns, or among Packing-bouse workers evidently
will be dependent upon the control of the infectlon in
animals and precautions on the part of those handling
infected stock.

The cases contr cted by workers in

packing-houses call for special mention.

The infection

in these instances ls clearly an occupational disease.
The patients have be-en un able to work for a period
varying from ?Pe month

to five months.

For. compen

sation to be obtained by the workmen; 1 t must be re-

. cogn1zed that undulant fever among packing-house
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workers is an occupational disease.fl (27).
It should be emphasized that the use of raw milk
is not the only way in which brucell0-81s can be con
tracted. It was sno�n by Brown in, 1929, that ·
B-rucella abortus organisms would remain all ve in raw
cream for e�ght to ten days, and in butter made Irom
raw cream for more than 140 days. {28)
In Ha.rdy' s study or. cases occurr-1ng in Iowa, he
had found some eases in packing-house workers who had

·•

not had any opportunity for infection by drinking raw
milk. This led him to postulate- that the ekln mlgbt
also be a portal of entry for the organisms.

Exppr1-

L

mental work was done with guinea-pigs with the follo$1ng results:

"Our experiments s_how that the normal

skin of g�1nea-p1gs 1s more vulnerable as a portal of
entry than is the digestive tract, and the ep1dem1o
log1cal evidence indicates that the same is true of
humans.

Since the organisms gain entrance without, {laus-

ing any local lesions, the probable portal can _pe determ1ned only by consideri:qg carefully the typ�s of ex
posure, the dos.age, and the resistance to invasion at
the different portals.
On a oonsidera r ion of these points 1\ seems pro
bable that Br. melttensis frequently gains entrc1:noe
tbro.ugh the skin to reproduce undulant fever 1n man.
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Furthermore, �_0ing from experimental data, ingest

ion 1s not a eat�sfactory explanati�n of the natural
and re·aay transm1ss1on of cont�iou-e abOrtion ·among
animals, and we believe that:, .for- animal Infection
also, more eonsidera�ion should be given to the skin as
a portal of entry for Br. melitensis. n

:

?9-30)

Beoause of the high inc 1dence of infectious
abortion ln cattle .and t.he rela · lve.ly low inc 1dence of
brucellosis, some authors continued to doub-t that
Brueella aoortus was pathe.gen1c· for man.
was that animals

!

One theory

ad ·be-eome infe·eted wlth Brucella

melitensis and that during �he animal pas�age the or
g�j).ism had gone thro�gh oe-rta1n biologic changes which
would alter its pathog�niclty for man.
pu� for-th by Giordano, in 1929. {31)

jhis theory_ was
Another theory

was that cattle had become infected w1 th the porcine.
atra�n- aDd that �his str..ain was the cause of tbe disease
seen in man.

This opinion was advanced by Blumer, alao

in 1929. (32) Hardy and his assoctates,1n 1936, called
attention to the fact that the highest incidence of
br�·lloa-1a wa-a in the West North Central states.

These

- state.a also produce over half of t,be h:?&J in the country.
They mentton-ed·, also, that Iowa had the hignest case

rate -Of brucellosis an� a la◊ one�f1ftn of a ll the �ogs in the
oo-unt_ry, and that· these OOfUi had a high inc.1-denee
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of Brucella

infection. (33)

Gershenfeld and Butts also

called attention t o the disparity between the number of
infected herds and the incidence in man.

They.suggested

that there might possibly be an insect veotor in the
areas 1n whicb the most brucellosis was aeen.(34)

An

other possible manner of infection was mentioned by
these authors.

This method was the eating of 1mproper1y

cooked me�t from infected animals.

This idea 1s some-

what strength.e,ned by the report of Levine, in 1943.

He

reported a series of cases seen in Cook County Hospital:
Among these cases were 17 packing- house workers.

"Of

these 17 packing-house workers, seven denied any direct
cont act with the meat, but finally .acknowle�ged eating

partially cooked meat, which, according to them, even
tasted raw.

Of those work1n� 1� direct contaet with

the meat, two of the 10 admitted cutting strips of meat
from tbe freshly slaughter-ed carcasses and grilling them
on steam radiators.

�bey also complained that the meat

was raw at the center.

Thus, of the 17 7,orkers, nine or

more than 50 p�rcent ate partially. cooked meat." (35)

Epidemiology 1s concerned not only with how the

disease is spread, but with who contracts tqe disease.
Tre lsrgest percentage of the cases reported in the lit
erature are 1n young mal:es.

This is thought t o be due
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to the gre.ater- chance for infect.ion because of oc -·
cupation.

In 1938, Gersb and .Mµgrage ran agglutina

tion tests on 5,000 samples of blood.Of the samples,
1.2 per cent showed posit.ive reactions.

The in-

cidence of positive reactions was approximately tbe
same for men as for women.

There also seemed to be a

relat1onshlp be·tween the occurrenee of positive im
munologic r.eact1o-ns an d the ingestion of raw m1lk. (36)
Although mos� of the cases which are reported are
those which have_been seen in young men, it 1s ev�de:nt
from the work of Angle and his associates, in 1938,

that ch fl. dren may often have .the disease.
group of school children were �kin tested.
cent were found t-o react posit1vely.

A l rge
9-0 per

There wa-e found ·

to be an increasing .percentage of wsitive skin reac.t_ors
in successive age groups up to early adulthood.

Cql-0red

children were found to have the lowest incidence of
positive reactions .

A seemingly imt>Ortant fac.t�r was

that 79.3 per cent of the positive reactors consumed
raw milk regular�y. (37)
Summarizing the epidemiol.og v of b.rtlCelloe1�, it
seems that 1 t 1s an occupational disease of packing
house workers, veterinarians, and farmers.

Outside of

these occupations the incidence seems to be equally
divided between males and females.

The manher of
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spr-ead 1s through infected milk, contact with. infected
an1malfl, and possibly through the eating of improperly
cooked meat fr.om infected animals.

There seems to be

some relationship between the bog population and the
incidence of brucellosis.

There 1s no direct relation

ship between the incidence of infection 1n cattle and
the incidence of the disease in.man.
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BACTERIOLOGY
Brucellosis is c�used by the Bruoella group of
,organisms.

These organisms are of the Family:

bacterlaceae, 1rr1be:
�here are

Parvo

Brucelleae, and the Genus: Brucella.

three organisms in this group.

They are the

Brucella abortus, the Brucella mel1tens1s, and the
Brucella suis.
bacillary forms.

These organisms are.small co�coid or
They vary greatly 1n size.

They may

be from o.4 to 3.0 mtcrons 1n length and from 0.4 to
0.8 microns broad.

The Brucella melitensis shows a

tendency to the coccobac1llary forms, which may be the
reason why Bruce described the organism as a micrococcus.
Brucella abortus is usually seen in the small bacillary
forms, while Brucella suis is practically always seen in
the bacillary ·form.

No differentiation can be made of

the basis of morphology alone.

The organisms may be

round singly, although 1n culture they are usually
found in short chains.
tb�y are not mottle.
but

They do not bave capsules ana
These organisms are gram-negat1�e,

show a tendency to irregular straining. (38)

The culture of the Brucella organisms 1s•rather

difficult.

They require soecial media, best growth

being obtained on liver infusion broth or agar.
optimum temoerature 1s 37°C.

The

On carbohydrate media it
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possible by means of serological tests.

The most

accurate test is the agglutination absorption test.

In

this test a monospec1fic serum, a serum from which the
antibody common to the other immunol,.og1ca.l types has
been absorbed, is used.

By using sera of· this. ty:pe,

agglutination 1s seen only in the sus�ension of the
organisms for which the serum is specific.(381

Other

tests will be mentioned ls the section on the Diagnosis
of Brucellosis

20

SYMPTOMATOLOGY
The symptomatology of Bruoellosi� or Undulant

fever 1s properly divided into two parts: acute
brucellosis

and ehronic brucellosis..

Most

of the eai:-ly ·

reports describe what 1s now known as acute brucellosis,
while the reports of. chronic brucellosis have appeared
in the literature comparatively recently.
probably because the acute disease is

This is

usually seen

when the infection is due to the Brucella melitensis,

and the chronic form is seen more often 1n Brucella
abortus and Brucella suis 1nfecttons, which have been
recognized only more recently.
In an anal ,•sis of 25 cases o-r a fever different
from typhoid and malaria, Godding, in 1891, reported
tbat the cases showed the following symptoms.

There

wis usually an acut� attack which lasted seven to ten
days; a fever wpich. showed morning remissions; and a
tendency to relapses, increasing debility, and anemia.

The subjective stgns _were headache, backache, chills
with

high temperatures, and pro-fuse sweats f.ollow1ng

the cbills.

Although the symptoms were very severe,

there was .a very low rate of mortality. (39)
in 1897, reported similar findings.

Hughes,

He also reported

palpable spleens, muscular and joint pains, a skin
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eruption, wbich had been mistaken f�r that seen in
typhoid, ·and a leukopenia w1 th a relat 1 ve lymphocy
tosis. (40)
The typical picture of acute brucellosis ls also
reported by Bassett-Smith.

11

In the most common form

there are marked waves of remittent fever of variable
length and intensity, separated from one another by

periods of temPorary absence of symptoms.

The onset is

usually gradual; the fever rises to 103° or 104° F.,

epistax1s, headache, enlarged spleen, coated tongue,

constipation, and sweats are marked, and sleeplessness

is common.

Each w ave lasts about a fortnight and these

typically get shorter and lees marked at each re

currence, but after each wave, depres;ion, with loss

of flesb increases and the sweats are more marked, with

occurrence of neuritis, swollen and painful joints, and
rarely orchi t1s·.

As the pat lent becomes more and more

emaciated and prostrate, he is subject to brqnch1t1s,

cardiac palpitations, and increased rheumatic-like pains,

the hair falls out or turns grey·•, and the patient ages
remarkably.

The duration is about four months, but com

plete convalescence is very slow. 11

cal changes which may occur.

He also mentions lo

These are cold abcesses,

costal sw ellings; irritation symptoms of the meninges
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and central nervous system , and a spe cial selective
action on the peripberal n-crve s .

Th ere may be a

oa rtial pe. ralysis of groups of mu-- cle s , the se cases
generally showing increased activity of the reflexes .

(41)
Box and Bamforth , in 1925 , reported a case of
acute brucellosis w~. ich sho wed a h e mmo rrl-ag ic ef fusion into the peritcineal cavity . (42)

Morana , re-

porting from the i s l and of lalta in 1928 , gives the fol lowing description of acute brucellosis .

" After an in-

cubation of from six to ten days t he patient has
headache, nausea, but no vomiting ; fever is also pre oent wi th sweats at ni~l·t; brochitis symptoms are
sometimes preoent in t h is state ; they disappear during
the course of the disease ; or t he lesions in t he
bronchi may go from bad to worse and pneumonia or
bronc h o - pneumonia takes its place .

Enlargement of the

spleen follo ws and the disease rapi d ly reaches its
fastigium to end after a more or less prolonged course .
The fever according to the course of the fever and other
symptoms , Three varieties of the di sease ~ave been des cribed: 1. A malignant type , which ends in death after
eight days of illness .

2.

n intermittent type , i n

which the characteri s tic wave is absent .

3. The typical

undulant variety with waves of variabel duration; with
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morning remissions and evening exacerbations; and
apyrexial periods running between precedent and sub sequent waves of temperature."

He also mentions the

presence of arthritis of the knee and hip joints and of
myocarditis .

(43)

Further studies of acute Brucellosis were rn~de by
Manson- Bahr and willough by in 1929.

"All cases , sur-

veyed as a whole , presented a definite diagnostic syn drome .

In t his category we include a high initial re -

mittent pyrexia, and it is necessary to emphasize that
this may be high (up to

105°F.}, ·resembling in t his re -

sp e ct that of true typhoid.

Splenomegaly of a consider-

able degree was present in every case, and should be
considered a prominent factor in making a diagnosis .
The intradermal ' rnelitine ' reaction of Burnet was tried
in three instances and proved to be successfu l.

11

In

their study they also reported the following findings .
"Arthritis pain was a con°tant and characteristic feature
associated with periarticulat effusions which are particularly transient , appearing first in one joint , and
then, after a short interval , in a neighbouring one .

In

addition to the joint pains , the fasciae and bony prominences exposed to the greatest amounts of pressure were
also affected.

'.Ye ,,,s;ould emphaslze that the headache of
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undu�ant fever, which 1s so persistent in the early
st�tes o� the infection, has a character1st1o of 1ta

own.

It is not so dul1 or stuporoue as that of trphoid,

but it causes intraetable insomnia w�tbout any appear
ance of de-11rium

or dulling of tbe

mental faculties.

11

'I'hey also mention the profuse and often drenching
sweats reporte-d by othera._ {44)

More recently studies have been made on xhe pres

ence of symptoms refer-able to certain part.a of the body,

One of these "Studies is on the effects on the respira
tory tract.

Orr reported in 1930 that 30 per cent of

his patients had a mild bronchitis. (45)

Further work

on bruoellosis and the respiratory system was reported

by Pa.retzky 1n 1936.

He reported two cases, proved to

be brucellosis, which showed crepitant rales in the up
per chest.

changes

X-rays taken at the time failed to show any

suggestive of pulmonary tuberculosis.

He

theorized that tbere was an inflammatory cond1 t1on in

the pulmonary parenohyman, but not producing an exudate
or a consolidation sufficiently massive to cast a shad
ow on the x-ray film. (46)

Bogert, also in 1936, re

ported cases o� bruoellosie which showed pulmonary

changed.

X-rays of his eases showed marked per1bronoh1al

infiltration or broncho-pneumontc consolidation. (47)
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Bea.tty, 1n 19·37, reported similar changes, and in ad
dition, thickened pleura, pleural adhesions, and
pleural effusions. (48)

Thts study was continued by

Beatty, and ln 1940, he yreporte d on a larger aeries of
cases.

The findings o·f his earlier work were substan
The resp1r atory symptoms mav lead to a

tiated. {49)
d1agn:,sis of

11

1nf-Juenza."

In the early repo rt:s, a common symptom ment 1oned
1s that of pains 1n the mu- cles and the ,1ointa.

Orr

repqr·te{! t'f!at many of bis i;,-a•.j.ents had neuromuscular
pains, but that less than one p�r cent had any definite
Joint inv-0lvement. (45)

O'Donoghue, in 1933, reported

a case of seu-tic artbr1t1s o� the hip which was proved,
by c ulture, to be due to Brucella melitens1s. (50)
Steindl-er, in 1940, raoorted on the orthopedic· comp.11catlon of brucellosis.
types.

He cla.��s1f1ed them under three

"ll) Involvement of single joint of pyogenic

e-haracter. (2) Polyartn1t1c d1ssemlnation of the sero us
type. (3) Osteomyel1t1s."

His cases were almost often

late sequeiae of the acute attack.

Th� charaoter1st1e

features we re preference Qf the lumbar soine, w1th
narrowing of dl�c and reactive bone production, rarity
of abcess formation, benig_n course, tendency to self
limitation, and response to conservative treatment.

{51)
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In a general discussion of brucellosis, Sj_mp-son,
1941, tells of the findings which may be found when
the central nervous system is invaded by the. Brucella
group of organtsms.

nRegiona.1 Brucella local 11zations

in the bra1n,spinal cord or meninges may occur during
the acute phase of the disease and'produce symptoms
and signs of encephalitis, myelitis, or meningitis,
sucb compl1cat1Jns are, however, more commonly ob
served as delayed manifestations of brucellosis•••
Tte involvement of the central nervous system may
produce the f irs� and only symp�oms of the disease. The

symptomatology varies greatly, depending upon the ex

tent of meningeal invasion and the presence of addit
ional complications
or peripheral nerves.

involving tbe brain, spinal cord,
In a patient with brucellosis, the

development of such symptoms and signs a severe head
ache, vertigo, diplopia, nuchal r1gtd1ty, aphasia,
psychic disturbances, and various forms of paralysis,
which are often evanescent, calls for examination of the
cerebra-spinal fluid.

Characteristically, the spinal

fluid wil� be under increased pressure and will show
pleocytosia, increase of albumin and a decrease of
globulin and sugar.

Since the ultimate diagnosis during

life depends upon the isolation 'and identification of
Brucella.from the spinal fluid, a particularly diligent
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effort should be made to recover the organism by
culture and by guinea pig inoculation." (52)

A

proved ca·se of Brucella meningitis was• reported by

Sanders 1n 1931.

This case recovered slowly. (53)

In this discussion we find that the Brucella
organisms can, and do, attack any and all parts of the
body.

�his characteristic helps to obscure the diag

nosis of acute brucellosis, and to make the diagnosis
of chronic brucellosis all the more difficult.
Many authors speak of chronic brucellosis, but
few of them make any really definite statement as to
the symptomatology of this disease.

A reason for this

is g1ven by Flagge, who states that brucellosis. is �
protean 1n its symptomatology.

He goes further and

saya that to look for pathognomon1c eigns and symptoms
ls certain to court disaster in diagnosis. (5,)

A

section, taken from an article written by Simpson in
1941 gives a -good picture of what may be expected in
chronic brucellosis.

"A recitation of all the symptoms

which have been ascribed to chronic brucellosis would
serve only to hetgh�en toe confusion which as yet
surrounds this baffling phase of the disease.
al,

In gener

it �ay be $tated that the three cardinal feat-

ures of most cases of chronic brucellosis are weakness,
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f1nd1ngs •...Mild degrees of rever may be present for
many weeks or months; there may be several months of
complete freedom from fever; sudden febrile exacer
bat"l.ons may occur, accompanied by an accentu&.t1on of
the prevailing symptoms, or by the development of
evidence of new regional symptoms affecting the res
piratory, caroiovascular, genitourinary, gastronintes
tinal, skeletal or nervous systems.

Pneumonia, endo

cardi tis, ·orch1t1s, epididymit1s, prostatis, oophor1tis,
cholecysti ts, hydrarthros1a, arthritis, spondyl1 tis,
ostsomyelitis, ocular complications or men1ngoencep
halit1s may be assoctated with the acute form of the
disease, but much more commonly appear several months,
or even years, after the often indefinite onset of the
chronic form of brucellosis.

In some instances such

delayed evidences of regional Brucella localization
may appear long· arter apparent recovery from the acute
manifestations of the disease.

All students of chronic

brucellosis have emphasized the aimost universal promi
nence -of symptoms which relate to the central nervous
system.

In addition to the o ·cast�nal

acute invasion

of the meninges, brain and spinal cord by Bruoella,
there 1s evidence that the endoant1gen of Brucella
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organisms circulating in the blood bas a toxic action
upon the central nervous system." (55)

Horn, 1n 1939,

reported that a large percentage of a group of patients·
which had been.classed as chronic neurotic types was
found to react to Brucella antigen.

These patients

pad practically all of the symptoms mentioned above.
He· further divided.them into four types. " (1) The
neuritic type, in which the Skeletal structures account for most of the aches and pains as arthritis, myo
aitis, or neuritic in origin. (2) The gastro-1ntestinal
type wherein the predominating complaints are dyspeptic
or referred to or have their or1•�1n in the abdominal
viscera. (3) The exhaustion type. ·(4) The anxiety de
pressed type. 11 (56)
Urschel, 1n 1943.

A s1:m1lar report was made by
He reported: " If the patient has had

the disease very long he almost invariably ends up with
a diagnosis of neurasthenia.

He colilplains of weakness,

lack of pep, poor appetite, constipation, mild abdominal
c�amping, weight loss, backache, bloatlng after eating,
loss of sexual desire, and many vague, indeterminate
symptoms.

The diagqosis of neurasthenia 1s qften en

couraged in the physician's mind by a definite psychon
eurot1c trend 1n the patient's thinking.

Few cases of

true psychosis are _reported in undulant fever, but
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insomnia, depression, irritability and re stlessness
are common.

These may be induced by the fact that

the patient has been 111 over a number of years, that
he has received almost every conceivable type of treatment and diagnostic regime, that he has·been told he
bad ... liver trouble,' 'bowel trouble,' 'kidney trouble,'
and many other kinds of 'trouble,' that all tbe medi
cations r.iven to him for vaTious conditions have been
ineffective, and that he continues to feel all in•.••
Psy-choneurosis is a justifiable outlet in some of these
cases.

Some physicians scoff at the chronic phase of

the disease and can legitimately· point ou t the fact
�hat all of the above-mentioned symptoms may be found
in patients suffering from more clearly described en
t1 t1es.

The present methods of diagnosis of chronic

brucellosis are admittedly 1nadequate,.but the writer
feels that the diagnosis must not be excluded on one
test only, as ls the commonly accepted practice among many physicians at th1s t1me." (57)
Still anoth�r writer, Schmldt, speaking of the
chronic ppase· of the infection, made these statements.
•The chron1c pbase may continue for years without an
acute exacerha1 ion, or acute phases may occur at 1rregular intervals, last�ng for several days or more
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w1 th subsequent 1-mprovement.

In the chronic phase,

the pattent is usually unaware of the presence of a
low grade fever.

The usual co inplaint.s are weakness,

vague pains, such, as an obscur-e headache, arthr1t1s,
mya.lgia, neuralgia, epigastric distress, cough, mental
depression, 1nsomnta, and many other less commonly
noted symptoms.

Weakness and fatigue a.re generally

present with one or more of the above complaints. Pos1t1ve findings on physical examination are usually ab
sent.

Loss of weight 1s not commonly noted, but care

ful check cf· temperature may show the presence of a low
grade fever.

Low blood pressure is frequently present.

In these cases
fatigue is usually attributed
to the by.
,
potension and the true diagnosis is missed.

11•

(58)

In view of the many symptqms set forth 1n the pre
ceding quotations, it is surpr.1s1ng that the diagnosis
of chronic brucellosis is not mlssed oftener than it 1s.
One of the disease which is often confused with chronic
burcellos1s 1s another chronic disease, pulmonary tuber
culosis.

Schneider, in 1930, called attention to the

poss1b1lfty of making this mistake 1n diagnosts.

He re

pQrted that the constitutional symptoms usuall_y present
1n acute pulmonary .tubercules1s are also seen in
bruoel1-osis.

.:e also states t hat a diagnosis of c.-·.ronic
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pulmonary tuberculosis sooul� not be ma.de unless it
could be substantiated by laoorato'ry and X-ray find

ings. (59)

Brickman, in 1931, also mentioned the

nec.ess1t.y of differentiation between brucellosis and
pulmonary tuperculosis. (60)
Among the gastro-1nt'est1rial complaints wb1ch may
be noted in chronic bruc�llosis is that of "gall-bladder"

disease.

Such JJ. case was reported by MacQulddy and

Martin, 1n 1934.

The case was that of a woman wbo

was known to bave had brucellosis 1n 1928.

She had re

ceived a course o� vaccine therapy without results in
1928.

In 1929 she received another course, also without

results.

In 1930 she was treated with irtravenous

acriflav1ne and then with an autogenous vaccine.

In 1932

the authors gave her a course of autogenou� vaccine.

The

result was some relief of symptoms and a fall in the
· titer of the agglutination reaction.

Four months later

she again has a high titer and a second -course of
autogenous vaccine, more concentrated and in larger a
mounts was given, again with a lowering of the agglut1nation titer.

In 1934 gall bl�dder symptoms were noted.

A duodenal dra�nage was done�

In the gall bladder bile ,

organisms were found which were proved to be Brucella
organisms. (61)

Thls case had a duration of six years,
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definitely putting it in the group of cases designated
as -0hronic brucellosis.
Because of its protean symptomatology, the diag
nosis of c i.- ronic burcellosis is usually made by the ex
c lusion of all other �oss1b111ties.

This requires a

careful history, a complet� physical exam1natton, and
careful consideration of all the laboratory data which
are at han�.

Chronic bruoellos·1s will never be aiag�

nosed as such unless the phy�ician is somewhat cons'

cious of the many forms that this disease may take and
of the prevalence of this dise1;1.se in the mid-Western
states.
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DIAGNOSIS
As can be seen from the protean symptomatology;
especially of chrqnic bru-e-ellos1s, the diagnosis of
- s a.n aid wou ld be
this disease without the laboratory a
very difficult .

It was not until 1897 that another

meth:>d of diagnosis than the history and the ·pbys1ca.l
signs and symptotns, and blood cultures was discovered.
this work was done by Wr1ght and Semple.

They showed

that a suspension of Brucella mel1tensis would be ag
glutinated by the addition of serum from a patient
suffering from Malta fever.

On the origfnal case ag

glutination was seen in serum dilutions up to 1:5900.

They found no difference in the reaction 1f dead

bacteria were used instead of live cultures. (62)
This work was confirmed by B1rt and Lamb, in 1899.
They also showed that the agglutination reaction ap
peared quite early 1n the course of the disease. (63)
Further eonflrmat1on was reported by American workers,
Musser and Sailer, 1n 1899.

They diagnosed a case of

brucellosis by this method. (64)

Further work in this ·

field of diagnosis was· also done by Zammlt in 1900. {65)
The next step �orwara in the serum diagnos!s of brucello
sis was made by Mohler- and �1chhorn, in 1912, when they
reported t-he development of a complement fixat1on t.est.

(66)

Further s�udy of the serum diagnostic methods for
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brucellosis led to the di .:-covery that these tests were
not entirely specific.

The first cross-agglutination

reaction which was reported was discovered by Burra·
1n 1919.

He round that sera from cases of brucellosis

would a€·,_·lut1nate V. eholerae as well as Brucella
mel1tensis.

The aJ$glutinatiQns against

v.

cbolerae were

not in as high as tfr:,se against Br. melitensis. (57)
The next report of cross-ag�lut1nations was made by
Alice Evans in 1927.

She found that there was such a

reaction between Br. melitensis and Bact. tularense. She
recommended that al l sera, being examined for agglutina
tion against either organism, be examined for agglutina
tion against both, unless the history pointed definite
ly to one disease of the other.

She reported that the

organism against whtch there was the higher titer was
probably the organism whioh was causing the disease.

If

there was not difference in tbe titer against either or
ganism, she recommended the use of agglutination ab
s orption tests. (68)
Foll-owing the development of t he Manto-ux sktn test
for tuberculosis came a skin test for brucellosis.

This -

was first reported in American 11terature by Ragan, 1n
1928.

He credited the test to Trent1, of Rome.

In

this test, 0.1 cc or· .a filtrate from a twenty-day broth
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culture of the organism was injected intra-dermally •
.A. positive reaction was said to be present when a
raised olacque appeared at the site of injection 1n
s1x hours.

The plaoque was said to be red, pale, or

light grey 1n color and from four to six cm. in di
ameter. (69)

Murdock and Hall also reported such a

test in 1928. They credited the test to Oliver and
Massot.

The techn1c of making the test was similar,

and the same criteria were used in the interpretation
of the reaction. (70)

The confirmatory wor� on the

test was done by Giordano in 1929.

.,Killed suspen

sions of Br. abortus were tnj.ected 1ntracutaneously
in twen-tr-five �roved cases of undulant fever, produc
ing severe local reactions t,y the method employed. One
hundred controls similarly injected yielded negative re
actions 1n 99 per cent." (71)

Because of certain inadequacies 1n the agglutina
tion and intradermal tests in the diagnosis of bru·cel1os1s, Huddleson,' Johnson, and Hamann reintroduced
the onsonocytophagtc reaction.

It ts used in conjuct1on

w1tb the 1ntradermal test and the.agglutination reactiop.
(72)

The follow1ng table of relatlons between the ag

glut1na·tion test, the 1ntraderma.l test, and the opsono
cytopbagic reaction was set up QY Gould and Huddleson
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and was reported by Gould 1n 1937 (73)
Ag--;lut1nat1on
;.'est

Allergic
Skin Test

Opsonocytophagic Status toward
Power or Blood
Brucel1a

.Negative

Ne�at1ve

Cells negative to
20% slight phagocy::tosis

Susceptible

Negative

Positive

·cells negative to
40% marked phagocytosis

Infected

· Postt\ve

Positive

Cells negative to
40% marked phagocy
- tos1s

Infected

Negative

Post tive

Cells 60 to 100%
marted pbagocytosls

Immune

Positive

Positive

Cells 60 to i00%
Immune
marked pbagocytosls

'111th the aid of blood cultures, agglutination, re
actions, 1!)-traderma.1 tests, and the opsonocytophag ic re
action, one might think that the laboratory di�gnos1s
or brucellosis shoula be quite easy.

This 1s not so, -as

by following th� laboratory tests alone, one can be led
into making the wrong diagnosis at times.
long been

ft

There has

controversy as to which of these tests 1s

the most spec1f1c and a� to what 1s necessary to make a
dlag,nosis or brucellosis.
All of the men who bave worked with brucellosis are
agreed that a poa1 -ti ve blood culture absolutely makes a
diagnosis. of brucellosis.

We cannot, boweve�, rule out
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tbis disease on the basis of only a negative blood
culture a.lone.

In 1912, Bassett-Smith pointed out

that the blood culture was usu�lly obtainable only

in the early stages of the disease. (74)

In

addition to

culture of the organisms from the blood, they have also

been cultured from the stools. (75)

MacQ.u1ddy and

Martin, in 1934, �eported having cultured Brucella
organisms from the gall bladder. (61)

It w ould seem

that obtaining a pos1 t1ve culture of Brucell-a organisms
would be sufficient to make the diagnosis.
Because of the presence of agglutinins 1n the
blood for organisms of the Bruc.ella: group after the
di·sease has run 1 ts course, there has been some contro
versy as to how high a titer 1s necessary to make a diag
nosis.

In 1929, •Giordana and Ableson reported that they

considered a titer of 1:40 or higher to be diagnostic

of brucellosis. (76)

In the same year Hirschboeck

reported that a ttter of 1:80 was necessary to make a
dia�nosis. (77)

Ecklund, in 1931, s-ugg$sted that posi

tive ap;glut1nat1ons in dilutions up to and including

1:60 not be accepted as diagnostic evidence alone. (78)

Corpening gives the following reasons why a positive ag
glutination reaction m1&ht be present in low dilutions;
11

(1) .The reaction may not be specific; ( 2) the agglut-

1n1ns may ··have been acquired in a� secondary manner by
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absorption in the intestines from the agglutinis pres
ent in the milk that had be_en ingested; { 3) tbe agglµt 1n1ns may have been produce·d as the result of an in
fection s.ometime in the past; (4) they may indicate a
present infection.

It may be that one explanation

would apply in 0ne case and another explanation in an
other case.

Consequently, the degree of agglutination

necessary to justify a diagnosis depends largely upon
the history of the c a- ·se..- " (79)
Just as there has been controve.rsy over the diag
0

nostic significance of the a.gglutination reactions, there
has been a similar contr�versy over the reliability of
the 1ntradermal test.

Leavell and_ Amoss, in 1931, re

commended the use of the 1ntradermal test, especially in
cases which showed a negati ve agglutination reaction.
They recommended that separate tests be made -with a
number of different strains of B.rucella. (80) • The use of
the intradermal test in•cases which showed a negative
agglutination reaction was also recommended by Yeckel
and Chapman.

They were of the opinion that negative ag

glutination reactions and a negative skin test·were
sufficient to rule out brucellosis. (81)

Gould and

Huddleson recommended tbe use of the opsonocytophagic
re.:;.ction in conjunction with the· 1ntradermal test.

They
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also state that a negative intradermal usually will
rule out brucellosis. (82)

In a later report from the

same year, 1937, they state that 1ntr-adermal and agglutination tests will not differentiate present infection from past infection. (e3)

It would seem that

this test is a valuable aid in diagnosis and should be
included with the blood culture and �he agglutination re
actions as a means of diagnosis of brucellosis.

This

opinion was held by Keller, Pharris, and Graub, re
porting in 1938. (84)
It is apparent that we must r..ave some criteria for
the diagnosis of brucellosis.
was made by babe1n in 1927.

The following statement
"The diagnosis of Malta

fever must be made largely from the history and by ex•
clus1on of other d1se�ses and tbe use of clinical and
laboratory data at hand.
by:

The disease is characte�zed

(1) an undulatory type of fever, ranging as high

as 104° , often aqcompan1ed by ch1lle, with remissions
at intervals of a few days or a week;
ing usually from four to six months;
of tbe spleen;
blood cells;

(2) a course last
(3} enlargement

(4) high percentage of mononuclear
(5) special agglutinations -0f organisms

from the specific group and occasionally isolation of
them from the blood." (85)

It will be noted that most
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of_these points are from.the cl1n1cal picture, the l�bo
ratory data being used only for the confirmation of the
diagnosis.

Th is procedure was also recommended by

Magath and Plummer. {86)

Stein also recommends the use

of the laboratory as a means of confirming the suspected

diagnosis. {87)

Hirschboeck.

Another set of criteria is presented by

They are; "(1) the long standing and

variable'fever, with a•tenden cy to undula tions; (2) pro

fuse sweating; (3) the arthralgic pains; (4) enlargement

of the spleen; (5) the alert mental condition and.good

general appearance of the patient; (§) a normal or re
duced white blood cell count, with a tendency to mono
cytosis; (7) the agglutination test;- (8) the blood cul
ture." (77)
The question arises as to which test 1s the pro
cedure of. choice 1n the a1agnos1s of brucellosis.

A

report of work done by Martin and Myers at the Univer
sity of Nebraska, showed that the complement fixation
and agglutination tests were parallel 1n their results.
Tbey recommended the use of the agglutinati�n test be
cause it was much simpler than the complement fixation
test. (88)

During an epidemlc in Iowa in 1941, both

1n tradermal and agglutination tests were used.

The 1n

tradermal tests showed a hlgher percentage of positive
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reactors.

The op1n1on of the investigators, howe ver,

was that tbe agglutination test was second only to the
blood cluture·as an aid in clinical diagnosis. (89)
The use of laboratory tests for the diagnosis of bru
cellosis is crystallized nicely by Foshay in this state
ment:

"The final interpretation of positive tests 1n

terms of disease must therefore be made only in conjunction with clinical and blood findings Which are compat1vle with those caused by brucellosis. (90)
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TREATMENT

T�e treatment of brucellosis is almost as pro
tean as 1ts symptomatology.

The literature is full of

reports of successful treatment- or· it, but, cases are
also reported which recovered with n o treatment other
than supportive measures.

Because this disease is

characterized by exacerbations and remissions, one cannot be sure whether

the treatment has cured the pat

ient, or the patient has had a spontaneous remission.
For tbts reason the results of therapy must be weighed
ca.re fully before any def1n1 te conclusions as to the
vaiue of the treatment can be reached.

Another import

ant step 1n making a decision as to the value of treat
ment is the use of contre5r cases.

'rhi.s is difficult, as

cases of brucellosis are not seen frequently enough to
accumulate a large enough series so that definite con
c lusions can be drawn.

No report of a large series of

cases, treated by any method, w 1th an adequate number of
control cases 1s t o be found in the English lan�uage
journals.
The m o st important cons 1derat1on in the treatment
of brucellosis· is its prevention.

It has been s hown that

this disease is spread by the �rinking of infected milk,
contact with infected animals, and possibly by the

eating of poorly cooked meat from infected animals.
Ideally, the best m ethod of preventing 1-nfect1on 1n man
would be tbe eradicati_on of the infection in animals.
The next best method is the protection of humans from
the infection by other means.

Since tbe disease 1s

often milk borne, �t would seem that pasteurization of
milk would be one method of prevention.

Smith, in 1932�

showed that all methods of pasteurization were not
equally efficient in the killing of tbe Brucella or
ganisms.

He found that milk pasteurized by the "holding 11

method was usually free from organisms of the Brucella
groups, although some samples did sbow tubercle bacilli.
Milk pasteurized by the "fl ash" method showed Brucella
organisms 1n some instances, and showed more tubercle
bacilli than the milk pasteurized by the "holding"
method·. (91)
The prevention of contact infection is more dif
ficult.

The eradication of the infection in animals·

would do away with this means of infection.

Until this

can be done, the spread of the dise�se by contact infec
tion must be controlled by the use of protective devices,
such as rubber gloves, and by strict obeervence of hy
gienic Principles.

Immuntzat1on against brucellosis has

not been thought to be effective.

However, Kolme�,
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Bondi, and Rule, in 1940, reported the apparently
successful simultaneous immunization against both
brucellosis and typhoid fever by adm1n1stration of a
vaccine compc;,sed of 1,000 m1111on heat-killed B.
typhosus, combined with similar quantities of heat
killed Br. abortus and Br. melitens1s.

The vaccine

was administered subcutaneously 1n doses of 0.50, one,
and one cc. at weekly intervals._

No severe reactions

we�e seen after giving the vaccine.

Of those who re

ceived the vaccine, 96 per cent developed agglutinins
for B. typhosus, wh_ile all developed agglutinins. and
immune opsonins for Br. abortus.

Immun1zat1on did not.

appear to produce allergic cutaneous sensitization to
brucellergin. (92)

There have heen no confirmatory re

ports on the use of vaccine in the prevention of brucel1-::>sie.

This would seem· to be an ideal way to prevent

the infection in thos who must, because of occupation,
oome into contact with infected animals.
As in any other disease, treatment must be dir
ected at keeping up tbe ge·neral well-being of the pat
ient, as well as at the eradication of the dis�ase.

In

1912, Bassett-Smith gave the following outline of treat
ment.

"In treatment there are four main lines to be

followed:

(1) Maintain the patient's strength for· a
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prolonged illness by giving as much food as be can
assimilate.
vaccines..

(2) Attack the micro-organism by means of
(3) Avoid ·neuritis by administration of

yeast or yeast products.
ary anem1_a.."(74)

{4) Counteract the second-

Gumston, 1n 1925, suggested that the

patient be kept in bed and-be placed on a milk diet. He
also stated that the treatment was purely _symptomatic,
being directed towards the control of the fever and the
pain.(93)

A more recent article follows quite closely

the principles laid.down by Bassett�Smtth.
was written by Avery, in 1942·.

Tbis article

He recommends symptoma

tic treatment and very careful attention to the general
nursing.

ttRest in bed, even for the mild· cases is es

sential, and if the patien� is allowed up too early, a
relapse may occur.

The sweating may .require frequent

cb�nging of the patient's clothing, and flannel or wool
next to the skin is advisable.

High pyrex1a should be

treated by hydrotherapy•••• -Maintainance of nutrition.is
important and often difficult owing to the anorexia, but
if the chief meals are given during the morning, when
patients are feeling at their best, the loss of weight
will be minimized." (94)
The first types of specific treatment__ which will
be presented are those chemotherapeautic agents which are
of no value or of doubtful value.

The first of these 1s
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intravenous mercurochrome.

The fi rst report tn Eng

lish language journals was by Belvea, in 1g27.

In .

this case, 30 cc of one per cent sol�ble mer curocbrome
was given intravenously.

The admin1 �,trat1on of the

dr ug was followed by a sharp systemic reaction.
such treatmenw were given.

Two

At the· time of the report

the patient had been followed only 26 days after the
last tr€atment had been given.{95)

Todd, also in

1927, reported two cases which seemed to be cureo fol
lowing administration of intravenous mercurochrome. One
of his cases was a chronic case of one year durat·1on,
Both

the other an acute case of 16 days duration.

cases were seemingly cured following one treatment.
Both of these cases showed sharp systemic re ct1on fol
lowing the administration of the drug. (96)

From 'these

reports 1 t might seem that the use of intravenous mer
curoch.rome was a good treatment.
Such results were not obtained by all who tried ·
this treatment however, Howard and Reeder, in 1928, re
ported a case in which this type of treatment failed.
They also attempted to cure the disease by the.use of
acr1fl�vtne, which had been given favorable reports in
foreign journals, but failed in that type of treatment

also. (97)

The treatment of brucellosis with
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acr1flav1ne, despite th is unfavorable report, was
vocated quite weakly by Hoffman, 1n 1929. (98)

ad

In 1930,

however, Thurber reported seven cases which had been
treated with intravenous acriflav1ne and seven cases
which had not received this form of treatment.

The dur

ation of illness in those who had not received this
treatment was much _longer than in those who were treat
ed.

He stated that after four doses, ranging from 0.1

grum for the first dose to 0.3 gram ror t he third and
fourth doses, the maximum effect was obtained and fur
ther treatment was of no benefit., (99)

Apparently these

results were not obtained by other investigator£, as
tbere are no later reports on the use of anriflavine in
the treatment of brucellosis.
Attempts have been made to effect a cure of brucel
losis by eradicating the organisms from the bowel.
Leavell, Poston, and Amoss, in 1930, reported favorable
results from the use of methyl violet and from thion1n
in intestinal arucella infections.

The dyes were given.

by mouth and as retention enemas. (100)

There are no

further reports on this m tpod of treatment.
Another cbemotherapeautic agent which bas been
given a 11m1ted trial 1n the treatment of brucellosis 1s
"rletapben."

Fortney, in 1933, reported one case which
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had a clinical cure on this type or therapy, aithough
the agglutin ation titer remained high. (101)
used.

Still other chemo�herapeaut1c agents have been

One author advocated the use of neo-arsphenamine,

but no confirmatory reports are found.
suggested the use of
comwund.

11

Neumann, in 1936,

Fouadin 11 , a trivalent antimony

He had used it in ei�ht cases, all of which

showed a favorable response. {102)

There are no fur

ther reports of the use of th1.s agent alone.

None of

these agents has been prGVed to have a .beneficial ef
fect on thi•s dis ease.

Most of them seem to act by pro

ducing a severe syetem1c reaction, indication an action
similar to fev .:: r therapy which will .be d 1scussed later
in thts sect!.on •
.The earliest method of specific therapy was by the
use of anti-toxin or serum.
Aldridge, in 1898.

This was first reported by

He had used serum in five cases. Of

these five cases, two received no benefit, one was doubt
fully benefitted, and two showed definite improvement.
The cases ·; hich showed the best reeults were apparently
early cases. (103)

The next report of this type of

treatment was by Fitzgerald and Ewa.rt, in 1899.

They- re

port�d one case -rb1cb showed a delayed serum reaction
�fter the first injection and a severe serum reaction
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after the third and last dose.

This case was de�

finitely 1m proved after the use of the serum. (104)
These reports would indicate that anti-serum t'.erapy
did ncit have much to of fer in the treatment of b rucel
losis.

This was further emphasized by Dalton, in 1928,

who reported that serum therapy .alone was disappointing.
·(105)

Although most of the reports on the treatment of

brucellosis by the use of serum were dis appointing,
certain investi a tors continued in their work to develop
a serum wbich .. auld be useful in the treatment of this
disease.

Scully, in 1932, reported a case which was

benefited only after receiving repeated doses of a poly
valent serum made by immuniz1nc catt'le to Brucella meli
tensis and Brucella abortus. (106) ·
ireatment by whole blood transfusion and bY. the ad
ministration of immune serum ·should also be included in
the treatment by the use of serums �nd anti-toxins.
Querli and Nelson, 1n 1932, reported twn cases which had
been treated b.Y the use of wr.ole blood t1:ansfusion from

donors who had recovered from the disease.
tbe cases ·were benefited.

All ten of

The results were expla.ined

on tbe basis of a pas�.1ve immunity obta1,ned from the
donor. (107)

Kennan, in 1935, reported a cure by the ad

m1n1stra.tion of a small amount of convalescent whole
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blood intramuscularly.

The case showed gradual im

provement from that t1rae. ( 108)

Also in 1935, Kret

zler repor�ed producing a remission by the injection
of 1mmune serum. (109)

In thts type of treatment there

are no r�ports of a large enough series of cases for any
definite conclusions to be drawn.

None of the. authors

has reported any control series.

Also lacking are c-on

firmatory reports.

This type of treatment cannot be

considered to be of any benefit.
The

first step forward in the treatment of brucel

losis by the use of ant1-s��rum was made by 0 1 .:e11, in
1933.

He reported immunizing goats with detoxified vac

cine and preparing ant1-serum from the blood of the
goats.

Three cases were treated by this serum, all of

which showed definite clinical improvement.

Accompany

ing this clinical improvement was a reduction in the
hypersensitivity as shown by the akin test. (110)

A

further report on this type'of treatment was published
by O'Neil, Wherry, and Foshay, in 1935.
the serum had

been used in 26 cases.

At that time

Of these case·a,

20 showed definite improvement, two were doubtfully im
proved,

and f-our showed no improvement at all.

They

re

porte� that the therapeaut1c action of·the anti-serum
was probably by the induction of specific phagocytosis.
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These cases were moderately severe to severe in type,
but the average time for recover•:. was less than the av
erage recovery time of the cases. reported by Hardy,
which were of all degrees of severity. (111)

Another

favorable report on tbe use of serum 1n the treat ment
of bryeellosis was published by Foshay, in 1937.
11

Antibrucella serum, for either torse or goat, was

given in 77 consecutive acute cases for which complete
quantitive data are ava.tlable,

w 1th

post-therapeaut1c

observations periods of sufficient length to juetify
conclusions concerning permanent recoveries •••• NO pat
ient failed to make a permanent recovery, The average
duration of disease to serum adm1n1strat1�n was 7.6
weeks (minimum l w�ek, maximum 29 weeks).

The average

duration o-f fev•:r after serum was 16 pays (minimum less
than one day, maximum 90 days).

The average duration ot

s,ymptoms after serum was 29 days (minimum zero, maxlmum
nine months)

The averag-e total duratHm of dis-ease was

3. 9 months (minimum 1. 2 months, maximum 11.0 montt.s.)"
(112)

This would indicate the effectiveness of th1s type

of therapy, but there have been no confirmatory reports.
Until sucn reports appear, serum therapy cannot be con
sidered to be s pecific in the treatment of brucellosis.
�be next method of specific therapy wh1ch will be
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considered is vaccine therapy.
most as old as serum therapy.

Vaccine therapy 1s al
One of the early reports
He recommended the

was made by Bas&ett-Smith, in 1907.

use of vaccines , especially in the acute cases.

He re

ported that v·Acoine seemed to be contraindicated in a
cute cases. (113)

In 1910, Kennedy· reported on the use

of vaccines in acute brucellosis.

He used strain-speci

fic vacc1ne and reported that the best· results, in acut�
cases, were obtained by the administration of a series
of small doses at short intervals. (114)
were not obtained by all workers.

These results

Prynne, also in 1910,

reported a case 1n which an oral vaccine was used.

There

was a remission-, followed by a severe exacerbation wit�
marked muscle and j_o1nt pains.

The vaccine was again

given, and con trolled all of the physical signs w1th
the exception of ·the mu'7cle pains. (115)

Hitchens, in

1913, -sugg�sted the use of polyvalent vaccines , which
he felt would be of some value. (116)

The· use of auto

genous �accine was f1rst. recommended by Owen and Newham,
1n 1915.

Their case was not impressive as to result.

(117) . As with all types of treatment, the early re
ports would seem to indicate that the specific agent
be1ng tested is of some value.

After some time the ad

verse reports begin to appear.

Such an adverse report

·on vaccine therapy of brucellosis was submitted by
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Tbpmpson, in 1928.

He reported a case which showed no

improvement, al though large amounts of polyvalent va
ccine had been given. {118)
Vaccine therapy was given new life by the report
of Angle, 1n 1�29.

He reported us1ng·a polyvalent vac

cine in the treatment of ten cases of brucellosis.

This

vaccine was made from a mixture of five pathog�n1c
strains of bovine origin and one strain of pore tne ori
gin.

The vaccine was given in graded doses, 0.25 cc.

being given as the initial dose.

The dosage was in

creased by O.25 cc. every day until a d,ose of one cc.
was reached.

This was the upper limit of dosage.

The

vaccine was given until there was a SV6tem1c reaction
from the vaccine.

After this sy temLc reaction, only

mild reactions were seen and in some aasea no further
r�actlons were se-en.

All cases were improved and the

symptoms disappeared. (119)

In 1930, the Council on

Pharmacy and Chemistry of the Amer1c�n Medical Asso
ciation reported that seven of Angle's ten or1__g.1nal
cases had been seen up to one year after the last treat
ment arid none had had any recurrence of sympt-oms. ( 120)
Ey and Van Orsdall reported, in 1931, that they
had treated five cases with Sjmpson's vaccine and three
cases with the Jensen-Sal1sberry(Angle's) vaecine.
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Uniformly good results were seen in all cases. (121)
Simpson, in 1932, made this report of the use of vac
cines 1n the treatment of brucellosis.

"Comparison

with a series of untreated control cases appears to
indicate that the vaccine usually terminates or short
ens the course of the disease and prevents recurrence.
Since undulant fever is often characterized by natural
remissions, the value of any tberapeautic measure must
be interpreted with caution." (122)
A new type of vaccine was reported by O'Neil, in
1933.

This vacctne was Brucella abortus vaccine which

had been det.ox1f1ed with nitrous acid.
five cases which had been treated.

He reported

An interesting fact

about these cases was that 1n every instance clinica l
improvement was paralleled by desensitization to the
bacterial protein, as srown by,akin tests. None of the
cases had had a remission within a maximum period of.
two years after the initial infection. (110)
In contrast to the early reports that vaccine was
contraindicated in acute brucellosis, Harris, in 1934,
reported that early infections appeared to yie1d most
readily to vaccine therapy. (123)

A report, which ap

parentl1-- substantiates this opinion, was made by Beattie
and Rice, 1n 1934.

They reported that cases w 1 thout
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treatment had an ave rage duration of illness of nine
weeks� putting them in the class of acu"t.e brucellosis.
Cases which received vaccine had an average duration of
five and one-half weeks, indicating shorter convalescence ·
1n acute cases treated with vaccine. (124}

The unfavor

able early reports of the treatment of- acute brucellosis with vaccine may have been due to the m1atak1ng
of the systemic reaction, which seems to be necessary
for satisfactory results to be attained, for an unfavor
able reaponee.

Angle, 1n 1935, reported that the use of

a vaccine over a long P-erlod of time may prolong the
fev-er �y means of the allergic systemic reaction whioh
1t causes.

In these cases the· fever disappears- after

the vaccine 1s diseontinued.

This is not a failure of

vaccine, but is rather an allergic reat1�n to the vac
c1ne. (125)
A newer method of vaec1ne :therapy was in:troduced
by Urschel and reported by bim, 1n 1943.

ttFor the first

dose the patient was usually given 0.1 cc. o.f a 1-5
d 1:tution 6 f the st ook vaccine.

Th1.s was increased, de

pend 1ng on the reac�1on� by small a mounts 1n subse
quent 1nject1ons •••••The 1nlect1ons were given at weekly
intervals or, in severe cases, more often.•. Those re
ceiving lntrad:ermal vaccine averaged 19.4 treatments •.•
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Intradermal therapy showed 87 per cent improving, and
thirteen per cent not improving." (126)

As yet there

have been no confirmatory reports as to the effective
ness of this form of vaccine therapy.
The latest method of vaccine therapy, introduced
by Griggs, 1n 1944, may be thought to be an outgrowth
of the work by Urschel.

He had treated many cases with

stock vaccines and notices that chronic cases often
showed an increasing sensitivity to Bruc�lla vaccines,
even in small amounts of high dilutions.

Hts method of

treatment was to desensitize the patient to Brucella
ant1 :-en.

In ao�e .cases very small amounts were all that

would be toler.ated (as little antigen as that contained
in 0.0000004 of one bacterium).

The dosage is increas

ed oy small amounts as tolerated without reaction.

He

re:i;:x:,rts success 1n 80 of the M.rst 100 cases and in 85
to 95 per ce�t of the second 200 eases.

He recommends

the use of alternate immunizat:on and desensitization
in obstinate cases. (127)

There are also no confirma

tory reports of this type of therapy.

It would seem that

in obstinate cases it should be �1ven a trial.
Another specific theraneautlfic aerent w·hicb has
been advocated in the treat:ment .of brucellosis in
"Brucellin", a rr-act1on of Brucella cells obtained by
grow tng the organism 1n liver broth.

The bacteria-free
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·,gent 1s recovered from. the liver broth filtrate. This
agent was first reported
1933,,.

·b.Y Huddleson and Johnson"" in

They recoqi:nenaed the giving 01' 0.05· to 0.1 cc.

intradermally to det-ermtne the degree of sene1-t1v11:,y of
the patient.

If there was no marked reaction 1n 48

hours, the initial dose wa& given.

This initial dose

consisted of one ec. of :"Brueellin" 1ntramuscl!larly.
This 1s repeated at. three t.o four -day intervals until

four doses have been given.

This will usually proauce

a severe systemic reaction.

There 1s us�ally a tran

sient increase of symptoms during -the first 24 hours
after the admtnie�r�tton

or

the material.

If there was

a reaction from the 1ntraderma1 test, graded doses, be

ginning with 0.1 cc. and increasing gra.4ual'iy to one cc.
were given.

After the full dose was reached, three one

cc. injections were given.
ed 80 cases in this manner.

At that time they had treatOnly four did not show de

f1n1 te improvement under thls tvpe of therapy.
confirmatory rep�Ft was presented

by

Debono, tn

(128)

A

1935.

He had treated 105 cases of brucellosis with "Brueel11n".
Of these cases, 68 were acute and 37 were chron1c.

Of

the acute c ases, 58 were aborted duPing tbe first py
rexial wave.
improved.

Of the chronic cases, 20 were definitely

He noted that more marked systemic reactions

were seen in the chronic cases. (129.

Another oonfir-
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matory report on the use of tt-i3ruc-ell1n" was made by
..

Borts, Harris, Joynt, J€nn1ngs, and Jordan, 1n 1943.
They reported 77 cases of Brucella suis infection, seen
duri:pg an epidemic 1n northern Iowa in 1941.

These

cases had an average dura�ion of fever of six to eight
weeks.

All cases were reported to bade made sat1sfact-

.ory re.coverles. (130)

There have been no further con

firmatory Feports on the therapy w1 tb "Brucellin".
Protein shock therapy and artificially induced
hyperpyrexia have also been used in the treatment of
brucellosis.

The first report of this type of therapy

was by Miller, in 1933.

He reported. three case� which

were apparently cured after one injection of typhoid
vaccine intravenously. (131)

Also reported at the

same t1me was one case treated by Martson-cBahr.

This

patient showed marked improvement 1n three da ys after
the initial sh?ck. (132)

The next report of this type

of treatment was by Beaumont and Page, in 1935.

They

had one case 1n wh ieh very severe protein shock was
produced by intravenous typhoid vaccine with apparently
favorable results. (133)

A more comprehensive·study

with a larger series of cases was reported by Ervin,
Hunt, and Niles, in 1937.

They treated ten cases by the

intravenous injection of typhoid vaccine.

The results
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in all ten cases were very satisfactory with no re
currences and negative �gglutination tests after treat
ment 1n nine of the ten cases so treated. (134)

In

1937, Ervin and Hunt presented ten additional cases.

Nine of these cases were treated with intravenous
typhoid vaccine.

Symptomatic improvement was seen in

all of these cases.

The one case in which this type

·of treatment was not attempted was a ·case of eight years'
duration whose complaints were largely neuresthenic. {135)
A natural outgrowth of the treatment with protein
shock therapy was tbat hyperpyrexia, induced by the
Simpson-Kettering hypertherm, would be tried.

The first

report of a series of cases 1� which this method of
treatment was used was reported by Prickman and Popp, in
1936.

Three cases were treated by tnree elevations of

temperature.

In tbe first treatment the temperature was

raised to 104 ° to 105 ° F. for five hours.

The second

treatment consisted of raising the temperature to 105 °
to 106 ° F� for six hours.

The third and final treat

ment was an elevation of the temperature to 106° to
107°F. for five hours.
four-day intervals.

The treatments were given at

All the cases were improved after

the third treatment. (136}

A second report was made

by Prickman, Bennett, and Krusen, in 1938.

At that
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time tt,tey had treated 21 cases by this method.

Their

result,s, as reported at that time, were 80.9 per cent
cured and 19.1 per cent unimproved. (137)

Phalen,

Prickman , and Krusen, in 1942, presented a report of
three cas�s of brueellos1s spondyl1t1s wb1ch were
treated by physically induced hyperpyrexia.

In two of

the writers' three cases, «destructive lesions of the
spinal column were present and 1n one the clinical
signs and symptoms of acute spondyl1t1s without any sig
nificant bony changes were observed.

All the patients

made a recovery, with demonstrable repair of the bony
lesions in two cases."

Their earlier work had shown that

hyperpyrexia did not benefit common cases of spondylltis.
(138)

The most recent report concerning the use of arti-

ficial fever therapy is by Joy and Moor, in 1943.

They

have used this type of treatment in six cases of acute
brucellosis and in 12 cases of chronic brucellosis.
Their patients have been under observa:t..ion after treat
merit for oer1ods of from e1ght months to five years. For
patients remaining well after four years, they have used
the term, recovers, �nd for those observed for less than
four years, the term, clinical remission.

In this

series of eighteen cases, 13,or 72.2 p�r cent, have
shown clinical remissions.

"The percentage of remissions
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in the acute cases was 83, and in the chronic cases 66.
In seven of the cases in the series sulfonamides had
been used without benefit before the patients came for
fever therapy.

In only one of the four cases in which

sulfan1lam1de was used in combination with fever was it
of any apparent value.

Even in thts one instance its

effect was open to question." (139)
The mode of action of the foreign protein reaction
and of fever therapy in the treatment of brucellosis is
not exactly known.

Carpenter and Boak, in 1936, attri

buted the effect to the severe s•:stemic reaction pro
duced by the vaccine when 1� 1s USid. (140)

Ervin,

Hunt, and Niles, in 1937, made this statement.

"One is

impressed by the fact that almo�t any substance which
will bring about a sharp thermal reaction will act
iavorably on the infection of undulant fever •.•. While
the observations report'ed 1n this study do no·t explain
· why the patients recovered, we do feel that inasmuch as
they were infected with a specific organism, the results obtained strengthen the theory that the injection
of typhoid and paratyphoid bacilli s�imulate a general
non-specific lmmunogenic reaction." (134)

Algie, 1n 1940, made this statement.

Angle and

"A review of the

11t erature would 1nd icate that one of the "sbock 11
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methods of therap.y perbapa represents the best method
available.

The evidence 1n hand would point to specific

vaccine as the preferred method 1n tne group." (141)
This statement brings us back to the mode of action of
the vaccines, serums,and filtrates which hive been
mentioned previously.

Praet1cally all of the writers

advocating the use of sucb ::nater:la.ls also advocated the
giving of these agents until a sys·temic re..... ct1on was
seen.

These reactions all brought on a high tempera

ture for varying lengtha of time.

If such reactions were

not produced, the trea�ment was u�ually not beneficial.
It would seem that anything which would bring about a
febrile reaction, lasting over a period

or

several

hours wo�ia be beneficial 1n the trea\ment of brucel
losis.

Such results are seen in cases trEated by the

Slmpson�et tering hyl'.)ertherm.

Th1 s would seem to be a

treatment of choice.
With the advent of th€ &ulfanamide drugs, it was
natural that they would be tried .1n the treatment of
brucellosis.

As with other agents which ha.d been t.I"led,

the first reports were very glowing. (L42)

Frances, in

1938, reported that in vitro experiments showed a great
er suscept1b111t-y of Bruee1la abort.us to sulfanilam1de
than that shown

ey

Strept. pyogen� under the same
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conditions. (143)

Welch, Wentworth, and Mickle, 1n

1938, made tb1s statement.

"It appears to us that

sulfanilamide acts indirectly 1n Brucella infectlona by
increasing the opsonic power of the blood and thus
neutralizing the effect of the endotoxin or aggres
sin-like substance produced by this organ ism allowing
pbagocytosis to take place.

The fa.ct that it was not

possible to stimulate the opsonlc power of· the blood
toward Brucella of uninfected human be!ngs or guinea
pigs by treatment with sulfanilam1de would indicate
that an infective or immunizing ?rocess must be in
progress for the drug to stimulate pbagocytosis in this
disease." (144)

With all the favorable .. renorts
on the
.

use of sulfanilamlde in the treatment of brucellosis,
it was to be expected that unfavorable reports would
eventually appear in the literature.
report was by Bynum, in 1939.

The first such

He reported that he had

treated six cases with maximum doses of sulfanilamide
and bad been unable to obtain the satisfactory reauJ ts which bad been reported before.

One case even

developed brucellosis wt.1le on intensive sulf3.pilamide
treatment for gonorrhea. (145)

A review of the cases

presented up until early 1939 was made by �lumgart,
and Gilligan.· Of the 74 reported cases, 68 had shown
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rapid recovery under sulfanilamide therapy.

In most of

these cases tbe infection had been present for about one
month before treatment was begun.

This would place

most of these eases in the class of acu te brucellosis.
The temperature usually became normal between tbe second
an.J the twelfth days of treatment.

The drug was given

for an average period of six to seven days.

The agglut-

1nat ion. t1ter was seen to drop following trea�ment.

Of ·

the 68 cases which showed r:covery from symptoms and
drop of temperature t o · normal, 54 showed no relapses.
The remaining 14 cases showed one relapse, •·.:r.ich soon
subsided after a second course of treatment.
of a second relapse has been made.

No report

These cases had been

observed for periods of from one to 12 months following
sulfantlamide treatment.

·Most of the cases were proba

b1 y of the Brucella abortus type of infection.
dosage used varied widely.

The

Fever was seen to disappear

on doses of two to three grams daily.

The american

investigators seemed to favor the higher dosages of
four to six grams daily.

.In tbe cases· treated with the

higher dosages, there was less tendenc; to relapse.
Elumgart and Gilligan advise the giving of doses of
one-::-balf grain per pound per day (equivalent to five
grams per day in the case.of a 150 pgund ma_,n), with a
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maximum dosage of six grams per day.
g1ven in divided doses.

Tb1s sbould be

Tbey also recommended tb�

continuation of treatment for tbree to four days after
the d1sapp'earance of the ..fever. (146)

At tbe same

time as this review was published, Smith and Curtis re
ported a case of Brucella endocard1t1s which was not im
proved after three courses of sulfanilamide. (147)
Experimental work on brucellosis in laboratory
animals has also been done.

Kolmer, in 1940, reported

on the effect of five different sulfonamide compounds in
the treatment of .experimental brucellos 1s in mice.

"All

five of the .compounds employed in the treatment o.f acute
brucellosis of mice showed best therapeaut1c results in
the case of the 160 infected with Br. abortus.

Of the

160 ·1nfected with Br. mel1tensis, the compounds were
much less effective whlle of the 80 infected with Br.
su1s, the therapeautic effects were nil insofar·as sur
vival was concerned, although all appreciably prolong
ed the lives of the mice and especially in the case of
sul fan1lam1de and sulfapyridine.

11

(148)

Wilson and

Maler, 1n 1940, used sulfapyr1d1ne, 1n the tre?tment of
experimental brucellosis in guinea pigs.

They concluded

that the drug was too toxic to use in the treatment of
an infection in wh1.oh the mo rtall ty rate was as low as
it is in human brucellosis. (149)
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Horn, 1n 1940, made a study of the compiled cases
which had been treated with sulfanilamide.

He reported

that the great majority of the cases had been acute,
and they had been favorably influenced in the ration of
2:1.

He then reported 52 chronic cases of brucellosis,

treated with sulfanilamide, 1n which there had been
favorable reaction 1n the same ratio of 2:1 (150)
All of the early reports of the treatment of
brucellosis with sulfonam1des were of cases treated with
sulfan1lam1de.

In 1941, King and Lucas reported that

sulfapyr1d1ne had a curative action against Brucella
infections when it wasgiven frequently enough to main
tain a constant blood level. (151)

Heim, 1n 1942, re

ported pne case which showed remission of clinical
symptoms after the administration of 12 grams of
cibazol (sulfan1lamldothiazol). (152) _Davis, in 1943,
reported that since 85 per cent of his cases showed
gastro-1ntestinal symptoms, the dru� of his choice was

sulfasuxidine.
•
this drug.

Of his 18 cases, 10 were relieved by

He concluded that the primary focus of the

infection wasin the colon.

Relief_ of the symptoms· of

metastatic foci of infection was credited to the five
per cent of the sulfasuxidine which makes its appear
ance in the blood stream in the form of sulfathiazole.
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He recommends the use of sulfath1azole in the cases
which do not show gastro-intest1nal symptoms as the
main compla1nt. (153)

Sulfaguanid1ne was recommended

for t he treatment of brucellosis by Sarvis, in 1942.
Three cases were presented which had made rapid recov
eries followtng the administration of large doses of
this drug for ·three days, followed by smaller doses
for an additional three days.

He does not, however,

subscr.1be to the theory- that there 1s a focus of in
fection in the gastro-1ntest1nal tract. (154.)

A comprehensive review of the cases of brucel
losis treated by the sulfonamides was made by urschel,
in 1944.

He calls attention to the fact that acute

brucellosis is usually a disease of five to seven
weeks duration, and thlit in the cases treated by sul
fonamides, treatment was usually begun in about the
r1ftb week, with a disappearance of the fever one
week later.

He does n�t feel that such results can be

accepted without an adequate series of controls.

He

also presented letters from several of the leading
workers in the trreatment of brucellosis.

All.of the

letters, except one, stated that they did not believe
that the sulfonamides were of any value 1n the treatment
of brucellosis.

Urschel makes the following s.ta.tement.

,.
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"It ls impossible to form any va.11.d opinion from such
a small series of cases, but the weight of the evid
ence would seem to be on the side of those who feel that
the sulfonamides are no� indicated in the treatment of
human Brucella infections.

Brucellosis is a disease

characterized by spontaneous remissions and relapses,
and any form of therapy must be evaluated with this in
mind.

When the first reports on sulfonamide therapy

appeared in the literature, they were almost entirely
favorable, but each author reported only a few cases,
(usually one) wit h a follow-up observation period of
never more than a year, and usually only a few months.
As more complete reports app�·ared it was seen that not
only was the percentage of complete success less than
it first appeared, but t e number of relapses was sig
nificant.

Inasmuch as the sµlfon�mides are toxic drugs

it would seem that their use in brucellosis is question
able.

BN�ellin and vaccine bave been tried over a

period of mg,ny years and proved successful in

much

larger· numbers of cases than hs.ve been included in the
sulfonamide reports.

Their indications and oontra

indications are definit�, and the low. toxicity is
proved.

If any val id opinion can be p resented from the

preceding data, it would be this:

There is no evidence
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at the present time that the sulfonamides are of
enough benefit in the treatment of human brucellosis
to warrant their use. 11 (15- 5)
The most ree-ent re-port·on the use of sulfonamides
1n the treatment of brucellosis is by Spink and Hall, in
1945.

They reported that sulfadiaz1ne in therapeautic

concentrations, was effe�tive in inhibiting the growth
.of Brueella.

The most marked inhibition was in the

case of Erucella abortus.

They advocate the use of

sulfadlaztne 1n the treatment of acu te brucellosis due
to Brucella abortus in patients showing a good immune
response as reflected by the agglutination titer.

They

report that they have ha.d 11 tt·le success in the treat
ment of chronic brucellosis with sulfonamides.

They

also reporv ihat in cases with a post�ive blood cul
ture� the use of sulfonamides eradicated the bactere-
mla in every case, except one case which had a Brucella
· endocard1 tis.

They have u sed the drug in such dosage as

was necessary to maintain a blood concentration or ten
rng. per 100 cc. (156)

Wl th ,the discovery of eenic1llin and tbe. reports
of its favorable a-ction in infections resistant to sul
fonamides, work was begun to determine its effectlveness
.in brucellosis.

In "in vitro" experiments, as reported

by T'ung, ·1n 1944, the results were disappointing.

He
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found that some strains of all of the Brucella srqops
were inhibited by penicillin.

There were, however,

other strains in the same groups which were highly

. resistant to penicillin. (157)

From the preceding reports 1t would seem that
brucellosis, acute or chronic, 1s best treated by care
ful attention to the physical condition of the patient.
Ther� is not sufficient evidence that brucellosis can
be tr�ated suecesafully by t�e intravenous use of
antiseptics or dyes.
as

Serum therapy is promising, but

yet there have not been enough centrol cases to

make possible the formulation of any definite conclus
ions. . Vacc 1nes have been successful in a large number
of cases, when they have been given in such doses to
produce systemic reactions.

Artificial fever therapy,

whether produced by protein sroc� or by �hysically in
duced hy)erpyrex1a 1s of value in those cases which are
resistive- to other forms 01' treatment.

The treatment or

acute brucellosis with sulfonamides may be of some bene

fit, although there is not yet a large enough control
series of cases to warrant the f�rmulation of any de
f1n1te conclusions.

The treatment of chronic brucel

losis wlth sulfonamides has not, as �et, been proved to
be of definite value.

Penicillin is not indicated in
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the treatment of brucellosis.
The use of vaccines appears to be the treatment of
choice.

cases which do not respond to the use of vac-

cines should be treated by artificial fev-r therapy.
Sulfonamides may be used in acute cases due to Brucella
abortus, wbich show a good 1mmunolog1cal reaction.

This

is for the purpose �f increasing the number of cases
tr�ated by sulfonam1des in order that more def�nite con
clusions as to 1 ts value may be drawn.
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